Travere Therapeutics, Inc. TVTX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 97.9%+1.2pp | 96.7%+4.6pp | 92.1%-2.2pp | 94.4%— | |
| Operating margin | -12.8%+126pp | -138.9%+128pp | -267.2%+24.9pp | -292.2%— | |
| Returns | |||||
| Return on invested capital | -96.2%+151pp | -247.2%+176pp | -423.6%-77.6pp | -346%-226pp | |
| Efficiency | |||||
| Asset turnover | 0.8×+0.5× | 0.3×+0.1× | 0.2×0.0× | 0.2×— | |
| Liquidity | |||||
| Current ratio | 2.7×+0.7× | 2.1×-1.4× | 3.5×0.0× | 3.4×-1.3× | |
| Leverage | |||||
| Debt-to-equity | 0.1×-1.4× | 1.5×+1.4× | 0.1×-0.6× | 0.7×+0.6× | |
| Per Share | |||||
| Book value per share | $1.29+71.9% | $0.75-72.3% | $2.70+302% | $0.67-86.7% | |
| Valuation | |||||
| Market capitalization | $3.42B+125% | $1.52B+121% | $687.51M-49.1% | $1.35B-31.1% | |
| Price / sales | 7×+0.5× | 6.5×+1.8× | 4.7×-7.6× | 12.3×— | |
| Price / book | 29.8×+4.1× | 25.7×+22.2× | 3.4×-28.1× | 31.5×+25.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Travere Therapeutics, Inc.'s profit margins?
- Travere Therapeutics, Inc. (TVTX) runs a 98.6% gross margin and a -10.6% operating margin, with a -20.3% net margin.
- Where do Travere Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Travere Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.